Concepedia

Xiaoli Xu

XX

Statistics

Publications

53

Citations

2K

H-Index

26

Active since

1994

Affiliations

China Pharmaceutical University(Current)

State Key Laboratory of Natural Medicine

Yantai University

Xiaoli Xu is an author at China Pharmaceutical University specializing in medicinal chemistry, drug discovery, and pharmacology.

ORCID

Publications per year

1994–2023

53

Publications

53

Discovery of Potent Keap1–Nrf2 Protein–Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis

Zhengyu Jiang, Mengchen Lu, Lili Xu et al. · Journal of Medicinal Chemistry · 2014 · 252 citations · Full text

, , +17

NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction

Chao Zhang, Huijie Wang, Qichao Bao et al. · Oncotarget · 2016 · 124 citations · Full text

, , +17

Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO

Tao Wang, Fei Chen, Zhe Chen et al. · World Journal of Gastroenterology · 2004 · 117 citations · Full text

, , +17

Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer

Lei Wang, Lixiao Zhang, Li Li et al. · Science Advances · 2019 · 101 citations · Full text

, , +17

Structure–Activity and Structure–Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1–Nrf2 Protein–Protein Interaction Inhibitor

Zhengyu Jiang, Lili Xu, Mengchen Lu et al. · Journal of Medicinal Chemistry · 2015 · 88 citations · Full text

, , +17

1–5 of 53